इस एपिसोड के बारे में

अंग्रेज़ी
संयुक्त राज्य अमरीका

अनुलिपि 🔗

पिछले एपिसोड्स खोजें

Taylor & Francis के पिछले एपिसोड खोजें।

इस पॉडकास्ट के अन्य एपिसोड

First-line management of unresectable hepatocellular carcinoma: clinical perspectives from the CheckMate 9DW study by Taylor & Francis Group
In this podcast episode, the speakers discuss how the findings from the EMBARK clinical trial could translate into real world practice.
Over the past two decades, HER2-positive breast cancer has undergone a dramatic transformation in oncology. In this interview, Cristina Saura (Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Spain) reflects on witnessing this evolution firsthand, from the introduction of …
This podcast features two of the investigators from the international, randomized, Phase III EMBARK trial (NCT02319837) in conversation. EMBARK evaluated the efficacy and safety of enzalutamide plus androgen deprivation therapy and enzalutamide monotherapy, as compared with androgen deprivation t…
अस्वीकरण: इस पृष्ठ पर एम्बेडेड पॉडकास्ट और कलाकृति Taylor & Francis Group से हैं, जो इसके मालिक की संपत्ति है और Listen Notes, Inc. से संबद्ध या समर्थित नहीं है।